From May 30 to June 5, the inaugural “Divas of Sheba” Women’s Mission to Israel provided 21 women from all over North America with a stimulating opportunity to explore and support Sheba Medical Center and the country.
Over 10 years ago, Dr. Gabis founded the Keshet Center, one of the largest autism centers in the world. This state-of-the-art facility follows a personalized, family-centric approach to early diagnosis, intervention, and research of autism-related disorders.
Sheba Medical Center, the largest, most advanced hospital facility in the Middle East, takes pride in being recognized worldwide as a leading force in medicine.
JCI review explores the total effectiveness of patient safety and healthcare quality. During their appraisal of Sheba, every aspect of how the medical center functions was scrutinized against the demanding JCI criteria, which include more than 1170 measurable factors.
The Hemato-Oncology Division comprises world-renowned physicians and clinicians who apply the latest cutting-edge approaches to diagnosing and treating blood cancers. As the largest hospital in the region, Sheba treats a wide range of conditions and offers personalized treatments that are unavailable elsewhere.
AM was diagnosed with aplastic anemia in January 2018. Her erythrocyte, thrombocyte and neutrophil counts were extremely low. The six months of treatment she had in her country did not bring any results.
Prof. Dan Aderka, Head of the Gastrointestinal Cancer Service at Sheba, recently conducted research that brought an end to a long-standing controversy over the treatment regimen for Colorectal Cancer (CRC) patients. The study discovered that various combinations of chemotherapy and biological medicine directly affected the life expectancy of CRC patients, depending on the specific type of tumor.
A clinical trial to test a new palliative care technique for patients with upper abdominal cancer is underway at Sheba Medical Center – and the significant results are encouraging.
Dr. Golan’s research offers new hope for patients worldwide with pancreatic cancer, particularly pancreatic adenocarcinoma harboring BRCA mutations. The results showed that patients who received the POLO treatment did significantly better overall than those who did not receive the drug.
Researchers at Sheba Medical Center are advancing rapidly towards a cure for hemophilia, a bleeding disorder that prevents normal blood clotting. At present, more than 400,000 individuals suffer from hemophilia around the globe.
CONTACT OUR MEDICAL TOURISM DIVISION
Established in 1948, Sheba Medical Center is now the leading medical center in the region.